Cardinal Health, Inc. (CAH)

Basic

  • Market Cap

    $26.09B

  • EV

    $26.92B

  • Shares Out

    246.47M

  • Revenue

    $210.17B

  • Employees

    47,520

Margins

  • Gross

    3.35%

  • EBITDA

    1.25%

  • Operating

    0.92%

  • Pre-Tax

    0.24%

  • Net

    0.07%

  • FCF

    1.36%

Returns (5Yr Avg)

  • ROA

    2.58%

  • ROE

    -44.23%

  • ROCE

    11.52%

  • ROIC

    12.92%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $104.28

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    $822.59

  • Earnings (Dil)

    $0.61

  • FCF

    $11.15

  • Book Value

    -$14.13

Growth (CAGR)

  • Rev 3Yr

    10.77%

  • Rev 5Yr

    8.56%

  • Rev 10Yr

    7.74%

  • Dil EPS 3Yr

    -43.19%

  • Dil EPS 5Yr

    -23.65%

  • Dil EPS 10Yr

    -6.3%

  • Rev Fwd 2Yr

    9.44%

  • EBITDA Fwd 2Yr

    12.77%

  • EPS Fwd 2Yr

    15.56%

  • EPS LT Growth Est

    15.32%

Dividends

  • Yield

  • Payout

    326.35%

  • DPS

    $1.99

  • DPS Growth 3Yr

    1.16%

  • DPS Growth 5Yr

    1.2%

  • DPS Growth 10Yr

    5.6%

  • DPS Growth Fwd 2Yr

    2.21%

Select a metric from the list below to chart it

Jun '14
Jun '16
Jun '18
Jun '20
Jun '22
LTM

Total Revenues

145,534.0

152,922.0

162,467.0

181,364.0

205,012.0

210,172.0

Total Revenues % Chg.

6.4%

5.1%

6.2%

11.6%

13.0%

12.4%

Cost of Goods Sold, Total

138,700.0

146,054.0

155,689.0

174,819.0

198,123.0

203,129.0

Gross Profit

6,834.0

6,868.0

6,778.0

6,545.0

6,889.0

7,043.0

Selling General & Admin Expenses, Total

4,480.0

4,572.0

4,533.0

4,557.0

4,834.0

4,834.0

Amortization of Goodwill and Intangible Assets

621.0

524.0

451.0

324.0

285.0

278.0

Other Operating Expenses, Total

5,101.0

5,096.0

4,984.0

4,881.0

5,119.0

5,112.0

Operating Income

1,733.0

1,772.0

1,794.0

1,664.0

1,770.0

1,931.0

Interest Expense, Total

-294.0

-238.0

-180.0

-149.0

-93.0

-82.0

Net Interest Expenses

-294.0

-238.0

-180.0

-149.0

-93.0

-82.0

Currency Exchange Gains (Loss)

-13.0

-11.0

-8.0

-7.0

-1.0

Other Non Operating Income (Expenses)

-2.0

12.0

55.0

-16.0

11.0

9.0

EBT, Excl. Unusual Items

1,424.0

1,535.0

1,661.0

1,499.0

1,681.0

1,857.0

Restructuring Charges

-125.0

-122.0

-114.0

-101.0

-95.0

-91.0

Merger & Related Restructuring Charges

Impairment of Goodwill

-2,100.0

-1,200.0

-1,627.0

Gain (Loss) On Sale Of Investments

579.0

-2.0

2.0

Gain (Loss) On Sale Of Assets

508.0

-60.0

53.0

Asset Writedown

-20.0

-7.0

-19.0

50.0

-50.0

-60.0

Legal Settlements

-36.0

-5,741.0

-1,129.0

-109.0

302.0

370.0

Other Unusual Items

-16.0

-14.0

-10.0

EBT, Incl. Unusual Items

1,751.0

-3,772.0

323.0

-769.0

638.0

502.0

Income Tax Expense

386.0

-79.0

-289.0

163.0

376.0

345.0

Earnings From Continuing Operations

1,365.0

-3,693.0

612.0

-932.0

262.0

157.0

Earnings Of Discontinued Operations

Minority Interest

-2.0

-3.0

-1.0

-1.0

-1.0

-1.0

Net Income

1,363.0

-3,696.0

611.0

-933.0

261.0

156.0

Net Income to Common Incl Extra Items

1,363.0

-3,696.0

611.0

-933.0

261.0

156.0

Net Income to Common Excl. Extra Items

1,363.0

-3,696.0

611.0

-933.0

261.0

156.0

Total Shares Outstanding

299.0

293.0

291.0

273.0

251.0

247.0

Weighted Avg. Shares Outstanding

300.0

293.0

292.0

279.0

261.0

255.5

Weighted Avg. Shares Outstanding Dil

301.0

293.0

294.0

279.0

262.0

256.3

EPS

4.5

-12.6

2.1

-3.3

1.0

0.6

EPS Diluted

4.5

-12.6

2.1

-3.4

1.0

0.6

EBITDA

2,733.0

2,685.0

2,577.0

2,356.0

2,462.0

2,624.0